Local Context: Who This Reaches GLP-1 drug use is not evenly distributed across the country
Twenty-seven patients received acetyl-l-carnitine at a dose of 500 mg twice daily for 10 days intramuscularly followed by the oral intake of 500 mg for 50 days (arm A)
Some of the positive ones are: Significant reduction in the risk of heart attack s and strokes It helps clear fat from the liver (MASH) and reduces strain on the kidneys It combats chronic joint pain or general "puffiness" seems to disappear, likely due to anti-inflammatory effects The negative ones are quite common and well-known: Nausea, diarrhea, and constipation are very common (about 20-30% of users) Smelly breath , often compared to the smell of eggs Very rare: risks of pancreatitis, gallbladder issues and a rare type of thyroid tumor (not seen with humans yet, only in rats) And a side-effect thats related to almost every comparable drug: the loss of muscle mass
Toxic shock syndrome is an inflammatory condition caused by a bacterial infection that, like MIS-C, can result in low blood pressure, fever, and rash
Unlike GLP-1 medications, many of today's trending peptides havent been studied in large human trials